Krishgen is the only manufacturer of ELISA for pharmacokinetic studies of BsAbs, with 40+ drug targets in a sensitive, highly specific ELISA format.
Bispecific T-Cell Engaging (BiTE) Antibodies: A Promising Cancer Therapy
Monoclonal Antibody Drugs for Cancer
Monoclonal antibody drugs have emerged as powerful tools in the fight against cancer, revolutionising treatment approaches.
Popular Targets for Bispecific Antibody Drugs
Bispecific Antibody drugs gained popularity since approval of blinatumomab. 6 bsAb drugs are approved by the US FDA/EMA & 180+ are in clinical trials.